♥

Kopran Limited

ISIN : INE082A01010
NSE : KOPRAN
BSE : 524280
Face Value : 10
Industry : Pharmaceuticals & Drugs

EPS : 10.55
EPS (TTM) : 12.27
Price to Earning (P/E) : 16.61
Book Value : 101.68
Price to Bookvalue (P/B) : 1.72
Dividend Yield : 2 %
Return on Equity (ROE) : 10.96 %
Return on Capital Employed (ROCE) : 13.78 %

Kopran Limited share price (02-Apr-2026)
National Stock Exchange NSE
Open / Close	0 - 0 NAN %
Low / High	0 - 0 NAN %
Trade Volume	0
52 Week Low / High	0 - 0 NAN %
Bombay Stock Exchange BSE
Open / Close	115 - 120.5 4.8 %
Low / High	113.95 - 120.8 6 %
Trade Volume	9,002
52 Week Low / High	107 - 212.5 98.6 %

YOU MAY ALSO LIKE

High dividend stocks
High dividend yield stocks on Stock exchange NSE and BSE
Stock market course tutorial
Stock Market Investment Course explained in simple words.
Share Market basics for beginners
Share Market jargons in simple terms
CAGR Calculator
Check your investment returns using our CAGR / Investment Growth Calculator
How much money do you need to retire
Know how much money do you need to retire, before how much to invest ?
Low PE ratio stocks
Undervalued, low PE ratio stocks on Stock exchange NSE and BSE

Consolidated Standalone

CONSOLIDATED QUARTERLY RESULT FOR KOPRAN LIMITED

Date End	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
No of months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months
Net Sales	1428.28	1256.18	1169.68	1580.05	1488.8	1170.02	1525.9	1589.18	1860.81	1394.36
Total Income	1439.17	1262.66	1174.04	1602.23	1526.63	1193.89	1527.21	1613.46	1957.47	1420.63
Total Expenditure	1158.61	1124.64	1068.25	1456.84	1367.2	1106.9	1297.64	1353.37	1643.89	1212.74
Other Income	10.89	6.48	4.36	22.18	37.82	23.87	1.3	24.28	96.65	26.26
Operating Profit	280.56	138.02	105.79	145.39	159.43	86.99	229.57	260.09	313.58	207.89
Interest	12.87	7.87	12.79	22.39	17.78	18.3	19.4	22.36	25.87	21.82
PBDT	267.69	130.15	93	123	141.65	68.69	210.17	237.73	287.71	186.07
Depreciation	26.91	30.54	32.52	31.62	32.43	32.59	27.68	32.66	35.94	38.74
Profit Before Tax	240.78	99.61	60.48	91.38	109.22	36.1	182.49	205.07	251.77	147.33
Tax	65.65	23.66	13.94	21.91	28.83	8.37	44.8	47.14	65.57	36.39
Profit After Tax	175.13	75.95	46.54	69.47	80.39	27.73	137.69	157.93	186.2	110.94
Net Profit	175.13	75.95	46.54	69.47	80.39	27.73	137.69	157.93	186.2	110.94
Equity Capital	482.12	482.11	482.11	482.11	482.12	482.11	482.11	482.11	482.11	482.11
Face Value (IN RS)	10	10	10	10	10	10	10	10	10	10
Calculated EPS	3.63	1.58	0.97	1.44	1.67	0.58	2.86	3.28	3.86	2.3
Diluted Eps After Extraordinary Items	3.68	1.58	0.97	1.44	1.67	0.58	2.85	3.27	3.85	2.3
Diluted Eps Before Extraordinary Items	3.68	1.58	0.97	1.44	1.67	0.58	2.85	3.27	3.85	2.3

STANDALONE QUARTERLY RESULT FOR KOPRAN LIMITED

Date End	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
No of months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months
Net Sales	645.03	711.8	536.23	679.64	802.28	658.6	986.39	823.34	906.23	496.07
Total Income	666.27	713.53	683.61	691.24	823.02	673.42	1044.28	836.24	987.72	517.27
Total Expenditure	576.66	646.97	477.18	618.61	728.65	650.4	899.37	702.7	752.82	443.26
Other Income	21.24	1.73	147.38	11.6	20.74	14.82	57.89	12.91	81.49	21.2
Operating Profit	89.61	66.56	206.43	72.63	94.37	23.02	144.91	133.54	234.9	74.01
Interest	7.97	4.95	6.13	7.22	8.41	9.52	7.45	10.25	17.79	6.92
PBDT	81.64	61.61	200.3	65.41	85.96	13.5	137.46	123.29	217.11	67.09
Depreciation	10.61	10.81	11.23	11.19	10.89	11.24	11.63	11.72	11.62	11.97
Profit Before Tax	71.03	50.8	189.07	54.22	75.07	2.26	125.83	111.57	205.49	55.12
Tax	23.3	12.76	10.2	13.78	19.89	0.72	19.2	26.47	52.4	12.66
Profit After Tax	47.73	38.04	178.87	40.44	55.18	1.54	106.63	85.1	153.09	42.46
Net Profit	47.73	38.04	178.87	40.44	55.18	1.54	106.63	85.1	153.09	42.46
Equity Capital	482.12	482.11	482.11	482.11	482.12	482.11	482.11	482.11	482.11	482.11
Face Value (IN RS)	10	10	10	10	10	10	10	10	10	10
Calculated EPS	0.99	0.79	3.71	0.84	1.14	0.03	2.21	1.77	3.18	0.88
Diluted Eps After Extraordinary Items	1.08	0.79	3.71	0.84	1.14	0.03	2.2	1.76	3.17	0.87
Diluted Eps Before Extraordinary Items	1.08	0.79	3.71	0.84	1.14	0.03	2.2	1.76	3.17	0.87

Consolidated Standalone

CONSOLIDATED ANNUAL RESULT FOR KOPRAN LIMITED

Date End	Mar 2022	Mar 2023	Mar 2024
No of months	12 months	12 months	12 months
Net Sales	4775.21	5509.87	6145.92
Total Income	4881.26	5540.52	6292.03
Total Expenditure	3901.27	4991.91	5401.78
Other Income	106.05	30.65	146.11
Operating Profit	979.99	548.61	890.25
Interest	51.17	60.83	85.93
PBDT	928.82	487.78	804.32
Depreciation	111	127.12	128.87
Profit Before Tax	817.82	360.66	675.45
Tax	207.5	88.33	165.88
Profit After Tax	610.32	272.33	509.57
Net Profit	610.32	272.33	509.57
Equity Capital	482.12	482.12	482.11
Face Value (IN RS)	10	10	10
Reserves	3779.57	3910.34	4430.34
Calculated EPS	12.66	5.65	10.57
Diluted Eps After Extraordinary Items	13.77	5.65	10.55
Diluted Eps Before Extraordinary Items	13.77	5.65	10.55

STANDALONE ANNUAL RESULT FOR KOPRAN LIMITED

Date End	Mar 2022	Mar 2023	Mar 2024
No of months	12 months	12 months	12 months
Net Sales	2045.2	2730.95	3374.56
Total Income	2125.47	2891.81	3541.67
Total Expenditure	1891.07	2451.82	3005.3
Other Income	80.27	160.86	167.11
Operating Profit	234.4	439.99	536.37
Interest	29.53	26.72	45.01
PBDT	204.87	413.27	491.36
Depreciation	43.23	44.12	46.2
Profit Before Tax	161.64	369.15	445.16
Tax	44.2	56.63	98.79
Profit After Tax	117.44	312.52	346.37
Net Profit	117.44	312.52	346.37
Equity Capital	482.12	482.12	482.11
Face Value (IN RS)	10	10	10
Reserves	3305.13	3473.75
Calculated EPS	2.44	6.48	7.18
Diluted Eps After Extraordinary Items	2.65	6.48	7.17
Diluted Eps Before Extraordinary Items	2.65	6.48	7.17

Consolidated Standalone

CONSOLIDATED PROFIT / LOSS FOR KOPRAN LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Gross Sales	501.12 Cr	484.54 Cr	558 Cr	614.62 Cr
Sales	490.8 Cr	481.29 Cr	555.19 Cr	610.11 Cr
Processing Charges / Service Income	0	0	0	1,000
Net Sales	491.81 Cr	477.52 Cr	550.99 Cr	614.59 Cr
Increase/Decrease in Stock	15.52 Cr	-29.19 Cr	12.62 Cr	1.06 Cr
Raw Material Consumed	267.82 Cr	277.74 Cr	321.87 Cr	373.34 Cr
Opening Raw Materials	25.98 Cr	53.46 Cr	72.31 Cr	66.81 Cr
Purchases Raw Materials	274.48 Cr	293.36 Cr	292.04 Cr	373.59 Cr
Closing Raw Materials	53.46 Cr	72.31 Cr	66.81 Cr	73.09 Cr
Other Direct Purchases / Brought in cost	20.82 Cr	3.23 Cr	24.34 Cr	6.03 Cr
Power & Fuel Cost	16.65 Cr	19.27 Cr	23.16 Cr	24.52 Cr
Electricity & Power	16.65 Cr	19.27 Cr	23.16 Cr	24.52 Cr
Employee Cost	37.16 Cr	43.27 Cr	49.95 Cr	52.28 Cr
Salaries, Wages & Bonus	32.72 Cr	37.69 Cr	43.66 Cr	44.95 Cr
Contributions to EPF & Pension Funds	1.83 Cr	2.18 Cr	2.45 Cr	2.35 Cr
Workmen and Staff Welfare Expenses	2.6 Cr	3.4 Cr	3.84 Cr	4.22 Cr
Other Manufacturing Expenses	33.89 Cr	38.78 Cr	42.67 Cr	45.34 Cr
Processing Charges	6.51 Cr	7.54 Cr	9.02 Cr	7.72 Cr
Repairs and Maintenance	2.93 Cr	3.23 Cr	3.15 Cr	3.53 Cr
Packing Material Consumed	18.45 Cr	22.83 Cr	24.08 Cr	27.54 Cr
General and Administration Expenses	26.35 Cr	28.23 Cr	27.86 Cr	29.56 Cr
Rent , Rates & Taxes	3.12 Cr	2.33 Cr	2.77 Cr	2.9 Cr
Insurance	81.25 Lk	1.05 Cr	1.36 Cr	1.41 Cr
Printing and stationery	59.29 Lk	63.39 Lk	83.85 Lk	95.46 Lk
Professional and legal fees	7.79 Cr	7.16 Cr	8.13 Cr	9.36 Cr
Traveling and conveyance	1.04 Cr	1.69 Cr	2.31 Cr	3.24 Cr
Selling and Distribution Expenses	8.42 Cr	8.54 Cr	9.31 Cr	9.4 Cr
Sales Commissions & Incentives	7.96 Cr	7.94 Cr	7.84 Cr	7.79 Cr
Miscellaneous Expenses	4.4 Cr	3.64 Cr	11.77 Cr	4.72 Cr
Bad debts /advances written off	84.12 Lk	0	0	0
Provision for doubtful debts	0	0	15 Lk	0
Loss on disposal of fixed assets(net)	12.03 Lk	0	0	0
Loss on foreign exchange fluctuations	0	0	6.2 Cr	0
Total Expenditure	410.2 Cr	390.28 Cr	499.19 Cr	540.23 Cr
Other Income	18.15 Cr	10.76 Cr	3.06 Cr	14.67 Cr
Interest Received	29.33 Lk	1.32 Cr	1.7 Cr	30.07 Lk
Dividend Received	0	7,000	7,000	5,000
Provision Written Back	20.66 Lk	1.51 Cr	60.94 Lk	35.92 Lk
Foreign Exchange Gains	16.09 Cr	7.48 Cr	73.88 Lk	7.17 Cr
Operating Profit	99.77 Cr	98 Cr	54.86 Cr	89.02 Cr
Interest	6.24 Cr	5.12 Cr	6.08 Cr	8.59 Cr
Bank Charges etc	1.72 Cr	1.49 Cr	1.58 Cr	2.21 Cr
PBDT	93.53 Cr	92.88 Cr	48.78 Cr	80.43 Cr
Depreciation	10.19 Cr	11.1 Cr	12.71 Cr	12.89 Cr
Profit Before Taxation & Exceptional Items	83.34 Cr	81.78 Cr	36.07 Cr	67.54 Cr
Profit Before Tax	83.34 Cr	81.78 Cr	36.07 Cr	67.54 Cr
Provision for Tax	21.73 Cr	20.75 Cr	8.83 Cr	16.59 Cr
Current Income Tax	18.3 Cr	19.48 Cr	8.07 Cr	15.86 Cr
Deferred Tax	3.43 Cr	1.27 Cr	76.02 Lk	73.31 Lk
Profit After Tax	61.61 Cr	61.03 Cr	27.23 Cr	50.96 Cr
Consolidated Net Profit	61.61 Cr	61.03 Cr	27.23 Cr	50.96 Cr
Profit Balance B/F	-68.7 Lk	54.43 Cr	108.97 Cr	121.74 Cr
Appropriations	60.92 Cr	115.46 Cr	136.2 Cr	172.7 Cr
Other Appropriation	0	6.49 Cr	14.46 Cr	14.46 Cr
Equity Dividend %	15	30	30	30
Earnings Per Share	14.24	12.66	5.65	10.57
Adjusted EPS	14.24	12.66	5.65	10.57

STANDALONE PROFIT / LOSS FOR KOPRAN LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Gross Sales	222.93 Cr	204.6 Cr	273.18 Cr	337.48 Cr
Sales	217.52 Cr	203.44 Cr	268.98 Cr	331.52 Cr
Processing Charges / Service Income	0	0	2.78 Cr	3.49 Cr
Net Sales	222.83 Cr	204.52 Cr	273.1 Cr	337.46 Cr
Increase/Decrease in Stock	14.7 Cr	-3.93 Cr	3.55 Cr	-1.74 Cr
Raw Material Consumed	106.46 Cr	110.88 Cr	152.9 Cr	206.92 Cr
Opening Raw Materials	12.81 Cr	14.2 Cr	23.17 Cr	34.18 Cr
Purchases Raw Materials	89.97 Cr	116.62 Cr	127.18 Cr	190.21 Cr
Closing Raw Materials	14.2 Cr	23.17 Cr	34.18 Cr	31.83 Cr
Other Direct Purchases / Brought in cost	17.88 Cr	3.23 Cr	36.73 Cr	14.36 Cr
Power & Fuel Cost	5.68 Cr	6.51 Cr	7.58 Cr	7.89 Cr
Electricity & Power	5.68 Cr	6.51 Cr	7.58 Cr	7.89 Cr
Employee Cost	18.34 Cr	21.05 Cr	25.15 Cr	25.61 Cr
Salaries, Wages & Bonus	16.05 Cr	18.17 Cr	21.95 Cr	21.78 Cr
Contributions to EPF & Pension Funds	85.04 Lk	1.05 Cr	1.14 Cr	1.04 Cr
Workmen and Staff Welfare Expenses	1.44 Cr	1.83 Cr	2.06 Cr	2.35 Cr
Other Manufacturing Expenses	24.91 Cr	30.01 Cr	31.29 Cr	36.73 Cr
Processing Charges	5.01 Cr	5.95 Cr	6.7 Cr	7.72 Cr
Repairs and Maintenance	95.59 Lk	1.24 Cr	1.23 Cr	1.5 Cr
Packing Material Consumed	16.58 Cr	20.88 Cr	21.24 Cr	24.97 Cr
General and Administration Expenses	14.9 Cr	17.22 Cr	15.71 Cr	16.96 Cr
Rent , Rates & Taxes	2.74 Cr	1.66 Cr	1.23 Cr	1.47 Cr
Insurance	30.7 Lk	37.74 Lk	50.81 Lk	46.28 Lk
Printing and stationery	29.27 Lk	32.62 Lk	43.41 Lk	53.83 Lk
Professional and legal fees	5.81 Cr	5 Cr	5.62 Cr	6.35 Cr
Traveling and conveyance	57.73 Lk	1.08 Cr	1.44 Cr	1.94 Cr
Selling and Distribution Expenses	5.42 Cr	6.26 Cr	6.67 Cr	7.11 Cr
Sales Commissions & Incentives	5.25 Cr	6.09 Cr	5.74 Cr	5.92 Cr
Miscellaneous Expenses	2.27 Cr	1.26 Cr	2.34 Cr	1.11 Cr
Bad debts /advances written off	72.55 Lk	0	0	0
Provision for doubtful debts	0	0	21.03 Lk	0
Loss on disposal of fixed assets(net)	1.32 Lk	0	39.91 Lk	1.09 Lk
Loss on sale of non-trade current investments	0	22,000	0	0
Total Expenditure	192.68 Cr	189.26 Cr	245.18 Cr	300.58 Cr
Other Income	10.46 Cr	8.18 Cr	16.09 Cr	16.77 Cr
Interest Received	12.95 Lk	1.4 Cr	10.52 Lk	6.95 Lk
Dividend Received	0	7,000	14.56 Cr	4.93 Cr
Provision Written Back	8.94 Lk	83.68 Lk	3.51 Lk	28.94 Lk
Foreign Exchange Gains	8.41 Cr	4.1 Cr	73.88 Lk	4.36 Cr
Operating Profit	40.61 Cr	23.44 Cr	44 Cr	53.64 Cr
Interest	3.81 Cr	2.95 Cr	2.67 Cr	4.5 Cr
Bank Charges etc	93.87 Lk	1.21 Cr	1.06 Cr	1.43 Cr
PBDT	36.81 Cr	20.49 Cr	41.33 Cr	49.14 Cr
Depreciation	4.1 Cr	4.32 Cr	4.41 Cr	4.62 Cr
Profit Before Taxation & Exceptional Items	32.71 Cr	16.16 Cr	36.92 Cr	44.52 Cr
Profit Before Tax	32.71 Cr	16.16 Cr	36.92 Cr	44.52 Cr
Provision for Tax	9.23 Cr	4.42 Cr	5.66 Cr	9.88 Cr
Current Income Tax	5.76 Cr	3.75 Cr	5.87 Cr	10.08 Cr
Deferred Tax	3.48 Cr	67.31 Lk	-20.93 Lk	-20.29 Lk
Profit After Tax	23.47 Cr	11.74 Cr	31.25 Cr	34.64 Cr
Consolidated Net Profit	23.47 Cr	11.74 Cr	31.25 Cr	34.64 Cr
Profit Balance B/F	40.17 Cr	57.15 Cr	62.41 Cr	79.2 Cr
Appropriations	63.64 Cr	68.9 Cr	93.67 Cr	113.84 Cr
Other Appropriation	0	6.49 Cr	14.46 Cr	14.46 Cr
Equity Dividend %	15	30	30	30
Earnings Per Share	5.43	2.44	6.48	7.18
Adjusted EPS	5.43	2.44	6.48	7.18

Consolidated Standalone

CONSOLIDATED CASH FLOW FOR KOPRAN LIMITED

Year End	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Profit Before Tax	83.34 Cr	81.78 Cr	36.07 Cr	67.54 Cr
Adjustment	16.44 Cr	13.82 Cr	16.29 Cr	20.96 Cr
Changes In working Capital	-23.79 Cr	-110.81 Cr	-5.55 Cr	-30.91 Cr
Cash Flow after changes in Working Capital	75.98 Cr	-15.21 Cr	46.81 Cr	57.59 Cr
Cash Flow from Operating Activities	59.95 Cr	-33.48 Cr	34.02 Cr	43.26 Cr
Cash Flow from Investing Activities	-24.41 Cr	-84.42 Cr	-12.65 Cr	-43.55 Cr
Cash Flow from Financing Activitie	-34.57 Cr	122.82 Cr	-19.84 Cr	98.85 Lk
Net Cash Inflow / Outflow	97.28 Lk	4.93 Cr	1.53 Cr	69.46 Lk
Opening Cash & Cash Equivalents	83.45 Lk	93.53 Lk	5.87 Cr	7.4 Cr
Closing Cash & Cash Equivalent	1.81 Cr	5.87 Cr	7.4 Cr	8.09 Cr

STANDALONE CASH FLOW FOR KOPRAN LIMITED

Year End	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Profit Before Tax	32.71 Cr	16.16 Cr	36.92 Cr	44.52 Cr
Adjustment	7.38 Cr	4.17 Cr	-9.04 Cr	2.69 Cr
Changes In working Capital	14.1 Cr	-54.54 Cr	-4.68 Cr	-2.41 Cr
Cash Flow after changes in Working Capital	54.18 Cr	-34.21 Cr	23.19 Cr	44.79 Cr
Cash Flow from Operating Activities	48.77 Cr	-37.81 Cr	16.87 Cr	34.96 Cr
Cash Flow from Investing Activities	-8.51 Cr	-100.26 Cr	10.05 Cr	-6.27 Cr
Cash Flow from Financing Activitie	-40.14 Cr	138 Cr	-26.13 Cr	-24.08 Cr
Net Cash Inflow / Outflow	11.84 Lk	-7.31 Lk	78.57 Lk	4.61 Cr
Opening Cash & Cash Equivalents	20.6 Lk	32.44 Lk	25.13 Lk	1.04 Cr
Closing Cash & Cash Equivalent	32.44 Lk	25.13 Lk	1.04 Cr	5.65 Cr

Consolidated Standalone

CONSOLIDATED BALANCE SHEET FOR KOPRAN LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Share Capital	43.25 Cr	48.21 Cr	48.21 Cr	48.21 Cr
Equity - Authorised	56.25 Cr	56.25 Cr	56.25 Cr	56.25 Cr
Equity - Issued	43.25 Cr	48.21 Cr	48.21 Cr	48.21 Cr
Equity Paid Up	43.25 Cr	48.21 Cr	48.21 Cr	48.21 Cr
Equity Shares Forfeited	10,000	0	0	0
Face Value	10	10	10	10
Total Reserves	201.78 Cr	377.96 Cr	391.04 Cr	442 Cr
Securities Premium	122.27 Cr	243.79 Cr	243.79 Cr	243.79 Cr
Capital Reserves	14.85 Cr	14.85 Cr	14.85 Cr	29.12 Cr
Profit & Loss Account Balance	54.43 Cr	108.97 Cr	121.74 Cr	158.24 Cr
General Reserves	8.14 Cr	8.14 Cr	8.14 Cr	8.14 Cr
Reserve excluding Revaluation Reserve	201.78 Cr	377.96 Cr	391.04 Cr	442 Cr
Shareholder's Funds	245.03 Cr	426.17 Cr	439.25 Cr	491.24 Cr
Secured Loans	33.28 Lk	15.16 Lk	65.07 Lk	44.61 Lk
Term Loans - Banks	27.78 Lk	0	0	0
Unsecured Loans	20.88 Cr	18.62 Cr	17.24 Cr	16.16 Cr
Inter Corporate Deposits (Unsecured)	2.3 Cr	2 Cr	2 Cr	2 Cr
Loans - Others	18.58 Cr	16.62 Cr	15.24 Cr	14.16 Cr
Deferred Tax Assets / Liabilities	4.99 Cr	6.27 Cr	7.08 Cr	7.87 Cr
Deferred Tax Assets	3.46 Cr	2.54 Cr	2.7 Cr	3.18 Cr
Deferred Tax Liability	8.45 Cr	8.82 Cr	9.78 Cr	11.05 Cr
Long Term Provisions	7.47 Cr	8.09 Cr	8.51 Cr	9 Cr
Total Non-Current Liabilities	33.67 Cr	33.13 Cr	33.48 Cr	33.47 Cr
Trade Payables	85.91 Cr	62.3 Cr	87.38 Cr	113.09 Cr
Sundry Creditors	85.91 Cr	62.3 Cr	87.38 Cr	113.09 Cr
Other Current Liabilities	28.85 Cr	31.4 Cr	32.85 Cr	22.8 Cr
Advances received from customers	2.38 Cr	1.64 Cr	1.81 Cr	1.07 Cr
Interest Accrued But Not Due	9.02 Lk	1.65 Lk	14 Lk	18.33 Lk
Short Term Borrowings	43.08 Cr	53.71 Cr	55.51 Cr	81.02 Cr
Secured ST Loans repayable on Demands	42.42 Cr	53.42 Cr	55.49 Cr	81 Cr
Working Capital Loans- Sec	32.01 Cr	37.5 Cr	37.82 Cr	54.44 Cr
Short Term Provisions	2.84 Cr	4.17 Cr	1.23 Cr	1.63 Cr
Provision for Tax	2.11 Cr	3.18 Cr	0	18.45 Lk
Total Current Liabilities	160.68 Cr	151.59 Cr	176.97 Cr	218.53 Cr
Total Liabilities	439.38 Cr	610.89 Cr	649.7 Cr	743.25 Cr
Gross Block	157.31 Cr	206.81 Cr	233.83 Cr	263.47 Cr
Less: Accumulated Depreciation	45.12 Cr	56.12 Cr	68.84 Cr	81.76 Cr
Net Block	112.2 Cr	150.69 Cr	164.99 Cr	181.71 Cr
Capital Work in Progress	37.09 Cr	27.54 Cr	55.66 Cr	77.65 Cr
Non Current Investments	4.51 Lk	5.93 Lk	5.66 Lk	5.66 Lk
Long Term Investment	4.51 Lk	5.93 Lk	5.66 Lk	5.66 Lk
Unquoted	6.51 Lk	7.93 Lk	7.66 Lk	7.66 Lk
Long Term Loans & Advances	6.09 Cr	8.19 Cr	14.33 Cr	9.11 Cr
Other Non Current Assets	1.22 Cr	1.53 Cr	1.67 Cr	1.75 Cr
Total Non-Current Assets	162.43 Cr	196.01 Cr	250.63 Cr	289.22 Cr
Unquoted	6.51 Lk	7.93 Lk	7.66 Lk	7.66 Lk
Inventories	100 Cr	149.94 Cr	130.61 Cr	138.49 Cr
Raw Materials	53.46 Cr	72.31 Cr	66.81 Cr	73.09 Cr
Work-in Progress	35.04 Cr	55.87 Cr	43.5 Cr	19.57 Cr
Finished Goods	5.5 Cr	13.86 Cr	13.62 Cr	36.49 Cr
Packing Materials	4.16 Cr	5.68 Cr	4.08 Cr	6.38 Cr
Stores and Spare	1.84 Cr	2.21 Cr	2.61 Cr	2.96 Cr
Sundry Debtors	120.08 Cr	127.36 Cr	162.56 Cr	212.33 Cr
Debtors more than Six months	0	1.29 Cr	1.04 Cr	90.42 Lk
Debtors Others	120.68 Cr	126.52 Cr	162.12 Cr	211.96 Cr
Cash and Bank	6.9 Cr	57.13 Cr	12.58 Cr	14.2 Cr
Cash in hand	2.69 Lk	4.44 Lk	2.44 Lk	7.79 Lk
Balances at Bank	6.87 Cr	57.09 Cr	12.56 Cr	14.12 Cr
Other Current Assets	5.83 Cr	4.89 Cr	5.77 Cr	45.68 Cr
Interest accrued and or due on loans	6.92 Lk	4.09 Lk	7.11 Lk	7.27 Lk
Prepaid Expenses	1.35 Cr	2.35 Cr	3.54 Cr	42.71 Cr
Short Term Loans and Advances	44.14 Cr	75.55 Cr	87.55 Cr	43.34 Cr
Advance income tax and TDS	38.04 Lk	23.86 Lk	1.78 Cr	43.67 Lk
Total Current Assets	276.95 Cr	414.88 Cr	399.07 Cr	454.03 Cr
Net Current Assets (Including Current Investments)	116.26 Cr	263.29 Cr	222.1 Cr	235.5 Cr
Total Assets	439.38 Cr	610.89 Cr	649.7 Cr	743.25 Cr
Contingent Liabilities	21.08 Cr	40.74 Cr	19.87 Cr	18.07 Cr
Total Debt	66.3 Cr	74.55 Cr	75.24 Cr	99.23 Cr
Book Value	56.65	88.4	91.11	101.68
Adjusted Book Value	56.65	88.4	91.11	101.68

STANDALONE BALANCE SHEET FOR KOPRAN LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Share Capital	43.25 Cr	48.21 Cr	48.21 Cr	48.21 Cr
Equity - Authorised	56.25 Cr	56.25 Cr	56.25 Cr	56.25 Cr
Equity - Issued	43.25 Cr	48.21 Cr	48.21 Cr	48.21 Cr
Equity Paid Up	43.25 Cr	48.21 Cr	48.21 Cr	48.21 Cr
Equity Shares Forfeited	10,000	0	0	0
Face Value	10	10	10	10
Total Reserves	203.6 Cr	330.51 Cr	347.38 Cr	367.62 Cr
Securities Premium	122.56 Cr	244.08 Cr	244.08 Cr	244.08 Cr
Capital Reserves	14.85 Cr	14.85 Cr	14.85 Cr	14.85 Cr
Profit & Loss Account Balance	57.15 Cr	62.41 Cr	79.2 Cr	99.38 Cr
General Reserves	8.14 Cr	8.14 Cr	8.14 Cr	8.14 Cr
Reserve excluding Revaluation Reserve	203.6 Cr	330.51 Cr	347.38 Cr	367.62 Cr
Shareholder's Funds	246.85 Cr	378.72 Cr	395.59 Cr	416.87 Cr
Secured Loans	5.5 Lk	7.5 Lk	30.19 Lk	22.56 Lk
Unsecured Loans	2.3 Cr	2 Cr	2 Cr	2 Cr
Inter Corporate Deposits (Unsecured)	2.3 Cr	2 Cr	2 Cr	2 Cr
Deferred Tax Assets / Liabilities	2.31 Cr	3.03 Cr	2.85 Cr	2.67 Cr
Deferred Tax Assets	2.4 Cr	1.33 Cr	1.4 Cr	1.65 Cr
Deferred Tax Liability	4.71 Cr	4.36 Cr	4.25 Cr	4.32 Cr
Long Term Provisions	3.86 Cr	4.03 Cr	4.33 Cr	4.57 Cr
Total Non-Current Liabilities	8.53 Cr	9.14 Cr	9.48 Cr	9.47 Cr
Trade Payables	39.96 Cr	29.79 Cr	62.36 Cr	51.78 Cr
Sundry Creditors	39.96 Cr	29.79 Cr	62.36 Cr	51.78 Cr
Other Current Liabilities	14.72 Cr	10.95 Cr	12.27 Cr	11.48 Cr
Advances received from customers	2.08 Cr	1.25 Cr	1.45 Cr	99.4 Lk
Interest Accrued But Not Due	7.38 Lk	0	2.3 Lk	7.68 Lk
Short Term Borrowings	13.26 Cr	34.74 Cr	25.51 Cr	20.41 Cr
Secured ST Loans repayable on Demands	12.66 Cr	26.66 Cr	25.51 Cr	20.41 Cr
Working Capital Loans- Sec	10.65 Cr	26.66 Cr	22.8 Cr	14.75 Cr
Short Term Provisions	63.7 Lk	76.77 Lk	74.12 Lk	87.52 Lk
Total Current Liabilities	68.57 Cr	76.25 Cr	100.88 Cr	84.54 Cr
Total Liabilities	323.95 Cr	464.12 Cr	505.95 Cr	510.88 Cr
Gross Block	64.6 Cr	67.63 Cr	73.17 Cr	82.46 Cr
Less: Accumulated Depreciation	17.16 Cr	21.41 Cr	25.82 Cr	30.44 Cr
Net Block	47.44 Cr	46.22 Cr	47.35 Cr	52.02 Cr
Non Current Investments	158.79 Cr	259.43 Cr	260.07 Cr	261.27 Cr
Long Term Investment	158.79 Cr	259.43 Cr	260.07 Cr	261.27 Cr
Unquoted	158.81 Cr	259.45 Cr	260.09 Cr	261.29 Cr
Long Term Loans & Advances	3.74 Cr	3.92 Cr	4.1 Cr	4.71 Cr
Other Non Current Assets	4.13 Lk	14.18 Lk	48.86 Lk	46.86 Lk
Total Non-Current Assets	212.84 Cr	312.81 Cr	315.54 Cr	323.17 Cr
Unquoted	158.81 Cr	259.45 Cr	260.09 Cr	261.29 Cr
Inventories	27.5 Cr	41.51 Cr	47.6 Cr	49.49 Cr
Raw Materials	14.2 Cr	23.17 Cr	34.18 Cr	31.83 Cr
Work-in Progress	5.38 Cr	7.58 Cr	4.27 Cr	6.59 Cr
Finished Goods	4.05 Cr	5.77 Cr	5.53 Cr	4.95 Cr
Packing Materials	3.65 Cr	4.69 Cr	3.32 Cr	5.78 Cr
Stores and Spare	22.4 Lk	29.64 Lk	29.88 Lk	33.56 Lk
Sundry Debtors	49.46 Cr	59.13 Cr	83.81 Cr	87.8 Cr
Debtors more than Six months	0	32.36 Lk	36.43 Lk	43.85 Lk
Debtors Others	49.77 Cr	58.96 Cr	83.81 Cr	87.67 Cr
Cash and Bank	3.22 Cr	2.55 Cr	2.59 Cr	7.42 Cr
Cash in hand	1.43 Lk	3.69 Lk	1.37 Lk	5.2 Lk
Balances at Bank	3.21 Cr	2.52 Cr	2.58 Cr	7.37 Cr
Other Current Assets	3.14 Cr	2.07 Cr	2 Cr	1.88 Cr
Interest accrued and or due on loans	6.92 Lk	4.1 Lk	7.11 Lk	7.27 Lk
Prepaid Expenses	83.14 Lk	1.33 Cr	1.7 Cr	1.21 Cr
Short Term Loans and Advances	27.79 Cr	46.05 Cr	54.41 Cr	41.11 Cr
Advance income tax and TDS	38.04 Lk	23.86 Lk	68.83 Lk	43.67 Lk
Total Current Assets	111.12 Cr	151.31 Cr	190.41 Cr	187.7 Cr
Net Current Assets (Including Current Investments)	42.55 Cr	75.06 Cr	89.53 Cr	103.16 Cr
Total Assets	323.95 Cr	464.12 Cr	505.95 Cr	510.88 Cr
Contingent Liabilities	50.5 Cr	45.45 Cr	47.77 Cr	51.3 Cr
Total Debt	15.72 Cr	36.9 Cr	27.88 Cr	22.71 Cr
Book Value	57.07	78.56	82.05	86.25
Adjusted Book Value	57.07	78.56	82.05	86.25

Consolidated Standalone

FINANCIAL RATIOS (CONSOLIDATED) FOR KOPRAN LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Operational & Financial Ratios
Earnings Per Share (Rs)	14.24	12.66	5.65	10.57
CEPS(Rs)	16.6	14.96	8.29	13.24
DPS(Rs)	1.5	3	3	3
Book NAV/Share(Rs)	56.65	88.4	91.11	101.68
Tax Rate(%)	26.07	25.37	24.49	24.56
Margin Ratios
Core EBITDA Margin(%)	16.29	18	9.28	12.1
EBIT Margin(%)	17.87	17.93	7.55	12.39
Pre Tax Margin(%)	16.63	16.88	6.46	10.99
PAT Margin (%)	12.29	12.6	4.88	8.29
Cash Profit Margin (%)	14.33	14.89	7.16	10.39
Performance Ratios
ROA(%)	15.22	11.62	4.32	7.32
ROE(%)	28.34	18.19	6.29	10.96
ROCE(%)	30.4	21.4	8.3	13.78
Asset Turnover(x)	1.24	0.92	0.89	0.88
Sales/Fixed Asset(x)	3.3	2.66	2.53	2.47
Working Capital/Sales(x)	4.31	1.84	2.51	2.61
Efficiency Ratios
Fixed Capital/Sales(x)	0.3	0.38	0.39	0.4
Receivable days	77.53	93.2	94.82	111.32
Inventory Days	68.65	94.14	91.76	79.9
Payable days	69.38	108.83	81.67	97.72
Valuation Parameters
PER(x)	7.37	22.24	19.55	24.45
PCE(x)	6.32	18.82	13.33	19.51
Price/Book(x)	1.85	3.19	1.21	2.54
Yield(%)	1.43	1.07	2.72	1.16
EV/Net Sales(x)	1.04	2.88	1.08	2.17
EV/Core EBITDA(x)	5.15	14.03	10.85	14.95
EV/EBIT(x)	5.73	15.82	14.12	17.48
EV/CE(x)	1.17	2.25	0.92	2.25
M Cap / Sales	0.92	2.84	0.97	2.03
Growth Ratio
Net Sales Growth(%)	36.81	-2.91	15.38	11.54
Core EBITDA Growth(%)	110.81	-1.77	-44.02	62.27
EBIT Growth(%)	140.82	-2.99	-51.5	80.64
PAT Growth(%)	193.08	-0.93	-55.38	87.11
EPS Growth(%)	193.07	-11.13	-55.38	87.11
Financial Stability Ratios
Total Debt/Equity(x)	0.27	0.17	0.17	0.2
Current Ratio(x)	1.72	2.74	2.25	2.08
Quick Ratio(x)	1.1	1.75	1.52	1.44
Interest Cover(x)	14.36	16.98	6.93	8.86
Total Debt/Mcap(x)	0.15	0.05	0.14	0.08

FINANCIAL RATIOS (STANDALONE) FOR KOPRAN LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Operational & Financial Ratios
Earnings Per Share (Rs)	5.43	2.44	6.48	7.18
CEPS(Rs)	6.38	3.33	7.4	8.14
DPS(Rs)	1.5	3	3	3
Book NAV/Share(Rs)	57.07	78.56	82.05	86.25
Tax Rate(%)	28.23	27.34	15.34	22.19
Margin Ratios
Core EBITDA Margin(%)	13.53	7.46	10.22	10.93
EBIT Margin(%)	16.38	9.34	14.49	14.52
Pre Tax Margin(%)	14.67	7.9	13.51	13.19
PAT Margin (%)	10.53	5.74	11.44	10.26
Cash Profit Margin (%)	12.37	7.85	13.06	11.63
Performance Ratios
ROA(%)	7.22	2.98	6.44	6.81
ROE(%)	9.85	3.75	8.07	8.54
ROCE(%)	13.57	5.64	9.44	11.36
Asset Turnover(x)	0.69	0.52	0.56	0.66
Sales/Fixed Asset(x)	3.7	3.09	3.88	4.34
Working Capital/Sales(x)	5.24	2.73	3.05	3.27
Efficiency Ratios
Fixed Capital/Sales(x)	0.27	0.32	0.26	0.23
Receivable days	75.27	96.87	95.5	92.81
Inventory Days	56.22	61.56	59.53	52.5
Payable days	76.89	119.02	107.49	101.52
Valuation Parameters
PER(x)	19.34	115.58	17.04	35.97
PCE(x)	16.46	84.48	14.93	31.73
Price/Book(x)	1.84	3.58	1.35	3
Yield(%)	1.43	1.07	2.72	1.16
EV/Net Sales(x)	2.09	6.8	2.04	3.74
EV/Core EBITDA(x)	11.48	59.37	12.68	23.51
EV/EBIT(x)	12.77	72.8	14.09	25.73
EV/CE(x)	1.44	3	1.1	2.87
M Cap / Sales	2.04	6.64	1.95	3.69
Growth Ratio
Net Sales Growth(%)	24.29	-8.22	33.53	23.57
Core EBITDA Growth(%)	61.38	-42.29	87.71	21.9
EBIT Growth(%)	68.3	-47.64	107.07	23.82
PAT Growth(%)	109.2	-49.97	166.11	10.83
EPS Growth(%)	109.2	-55.11	166.11	10.83
Financial Stability Ratios
Total Debt/Equity(x)	0.06	0.1	0.07	0.05
Current Ratio(x)	1.62	1.98	1.89	2.22
Quick Ratio(x)	1.22	1.44	1.42	1.63
Interest Cover(x)	9.59	6.47	14.82	10.89
Total Debt/Mcap(x)	0.03	0.03	0.05	0.02

SHARE HOLDING PATTERN FOR KOPRAN LIMITED

Date	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoters %	44.25	44.25	44.30	44.30	44.49	44.49	44.51	44.49	44.49	44.49
FII %	0.50	0.51	0.34	0.41	0.34	0.39	0.48	0.84	0.68	1.31
DII %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.12	0.01	0.22
Public %	55.11	55.10	55.22	55.15	55.03	54.77	54.88	53.47	54.70	53.97

PEER COMPARISON FOR KOPRAN LIMITED

No.	Name
1	AMBALAL SARABHAI ENTERPRISES LTD
2	Cipla Limited
3	Dr. Reddy's Laboratories Limited
4	Procter & Gamble Health Limited
5	J.K.PHARMACHEM LTD
6	Lupin Limited
7	Lyka Labs Limited
8	MESCO PHARMACEUTICALS LTD
9	Morepen Laboratories Limited
10	Piramal Enterprises Limited
11	Torrent Pharmaceuticals Limited
12	Abbott India Limited
13	GlaxoSmithKline Pharmaceuticals Limited
14	Sanofi India Limited
15	Pfizer Limited
16	Bliss GVS Pharma Limited
17	Alembic Limited
18	Unichem Laboratories Limited
19	AstraZeneca Pharma India Limited
20	GUJARAT THEMIS BIOSYN LTD
21	JB Chemicals & Pharmaceuticals Limited
22	TTK Healthcare Limited
23	Jagsonpal Pharmaceuticals Limited
24	Gufic Biosciences Limited
25	Sequent Scientific Limited
26	Albert David Limited
27	IOL Chemicals and Pharmaceuticals Limited
28	Wanbury Limited
29	Kopran Limited
30	Aarti Drugs Limited
31	Orchid Pharma Limited
32	Biofil Chemicals & Pharmaceuticals Limited
33	Marksans Pharma Limited
34	IPCA Laboratories Limited
35	Kilitch Drugs (India) Limited
36	Krebs Biochemicals and Industries Limited
37	Neuland Laboratories Limited
38	Ind-Swift Limited
39	Hester Biosciences Limited
40	Parenteral Drugs (India) Limited
41	Sun Pharmaceutical Industries Limited
42	Hikal Limited
43	Caplin Point Laboratories Limited
44	Aurobindo Pharma Limited
45	Natco Pharma Limited
46	Bal Pharma Limited
47	BDH INDUSTRIES LTD
48	Venus Remedies Limited
49	Jubilant Pharmova Limited
50	Themis Medicare Limited

CORPORATE ACTIONS FOR KOPRAN LIMITED

Exchange Date	Purpose	Book Closure Dates
BSE 19-Aug-2024	Book Closure - Rs.3.0000 per share(30%)Final Dividend & A.G.M.	03-Sep-2024 05-Sep-2024
BSE 23-Jul-2024	Board Meeting - Quarterly Results	08-Aug-2024
BSE 16-May-2024	Dividend - Rs.3.0000 per share(30%)Final Dividend
BSE 08-May-2024	Board Meeting - Final Dividend & Audited Results	16-May-2024
BSE 23-Jan-2024	Board Meeting - Quarterly Results	07-Feb-2024
BSE 26-Oct-2023	Board Meeting - Quarterly Results	07-Nov-2023
BSE 17-Aug-2023	Book Closure - Rs.3.0000 per share(30%)Dividend & A.G.M.	08-Sep-2023 11-Sep-2023
BSE 17-Aug-2023	AGM - Rs.3.0000 per share(30%)Dividend & A.G.M.	14-Sep-2023 11-Sep-2023
BSE 31-Jul-2023	Board Meeting - Quarterly Results	10-Aug-2023
BSE 25-May-2023	Dividend - Rs.3.0000 per share(30%)Dividend
BSE 16-May-2023	Board Meeting - Dividend & Audited Results	25-May-2023
BSE 27-Jan-2023	Board Meeting - Quarterly Results	10-Feb-2023
BSE 01-Nov-2022	Board Meeting - Quarterly Results	11-Nov-2022
BSE 01-Aug-2022	Board Meeting - Quarterly Results	10-Aug-2022
BSE 29-Jun-2022	Book Closure - Rs.3.0000 per share(30%)Final Dividend & A.G.M.	08-Aug-2022 10-Aug-2022
BSE 29-Jun-2022	AGM - Rs.3.0000 per share(30%)Final Dividend & A.G.M.	29-Aug-2022 10-Aug-2022
BSE 27-May-2022	Dividend - Rs.3.0000 per share(30%)Final Dividend
BSE 13-May-2022	Board Meeting - Final Dividend & Audited Results	27-May-2022
BSE 24-Jan-2022	Board Meeting - Quarterly Results	03-Feb-2022
BSE 03-Dec-2021	Board Meeting - Preferential Issue of shares	08-Dec-2021
BSE 18-Oct-2021	Board Meeting - Quarterly Results	27-Oct-2021

CORPORATE ANNOUNCEMENTS FOR KOPRAN LIMITED

Exchange Date	Category File	Description
BSE 30-Oct-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation for Loss of Share Certificate
BSE 28-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS Allotment of ESOP shares
BSE 10-Oct-2024	General Announcements FILE	Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Compliance Certificate under Reg 74(5) of SEBI (DP) Regulation 2018
BSE 09-Oct-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation of Duplicate Share Certificate
BSE 01-Oct-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Company has received Intimation of Loss of Share Certificate
BSE 27-Sep-2024	Intimation FILE	Closure of Trading Window Closure of Trading window for Q2- 2024-25 results
BSE 11-Sep-2024	Outcome FILE	Shareholder Meeting / Postal Ballot-Outcome of AGM Outcome of 65th Annual General Meeting along with Voting Results and Scrutinizer Report.
BSE 04-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Credit Rating Credit Rating
BSE 30-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper Publication
BSE 17-Aug-2024	General Announcements FILE	Reg. 34 (1) Annual Report. Annual Report FY 2023-24
BSE 17-Aug-2024	General Announcements FILE	Business Responsibility and Sustainability Reporting (BRSR) Business Responsibility and Sustainability Reporting FY 2023-24
BSE 16-Aug-2024	Intimation FILE	Notice Of 65Th AGM Notice of the 65th AGM to be held on Wednesday September 11 2024 at 11.30 a.m. through VC/OAVM.
BSE 14-Aug-2024	Intimation FILE	Book Closure For Payment Of Dividend Book Closure for Payment of Dividend
BSE 11-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome Transcript of Kopran Limited Q1 FY 25 Earnings Conference Call
BSE 09-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper Publication of Results Q1 FY 2024-25
BSE 08-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Investor Presentation Investor Presentation for Q1-2024 results
BSE 08-Aug-2024	Outcome FILE	Results For The Q1 FY 2024-25 Unaudited Standalone & Consolidated Results for the Quarter ended on June 30 2024
BSE 06-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Post Result Q1 FY24 Earnings Concall
BSE 31-Jul-2024	General Announcements FILE	Updates Of API Unit Of The Company Updates in API unit of the Company
BSE 26-Jul-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Issue of Duplicate Share Certificates
BSE 23-Jul-2024	Intimation FILE	Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The First Quarter Ended June 30 2024 KOPRAN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2024 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results of the First Quarter ended June 30 2024
BSE 09-Jul-2024	General Announcements FILE	Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Compliance Certificate under Reg. 74(5) of SEBI(DP) Regulation for the Quarter ended June 30 2024
BSE 08-Jul-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Company has received Intimation of Loss of Share Certificate
BSE 08-Jul-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Company has received Intimation of Issuance of Duplicate Share Certificate
BSE 05-Jul-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Company has received intimation of Issuance of Duplicate Share certificate
BSE 28-Jun-2024	Intimation FILE	Closure of Trading Window Closure of Trading Window for the Period ended June 30 2024
BSE 12-Jun-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation of Loss of Share Certificate
BSE 23-May-2024	Compliance FILE	Compliances-Reg.24(A)-Annual Secretarial Compliance Annual Secretarial Compliance Report for the year ended March 31 2024
BSE 18-May-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome Transcript of Investors Meet held on May 17 2024
BSE 18-May-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper Publication

INSIDER TRADING FOR KOPRAN LIMITED

Exchange Dates	Activity	Qty & Price (%)	Person / Organisation
BSE 02-Jun-2023 02-Jun-2023	Buy Inheritance	289,000 @ 0.00 (0.61 %)	Mridula Somani
BSE 31-Mar-2023 31-Mar-2023	Buy Market	65,500 @ 0.00 (0.14 %)	Surendra Somani
BSE 31-Mar-2023 31-Mar-2023	Buy Market	28,500 @ 0.00 (0.05 %)	Surendra Somani
BSE 21-Jan-2023 21-Jan-2023	Buy Inheritance	270,500 @ 0.00 (0.56 %)	Mridula Somani
BSE 17-Nov-2022 17-Nov-2022	Buy Market	10,000 @ 0.00 (0.00 %)	HAZARIMALL SOMANI

BULK BLOCK DEALS FOR KOPRAN LIMITED

Exchange Dates	Activity	Qty & Price (%)	Person / Organisation
No Bulk Block details found

DIVIDEND BY KOPRAN LIMITED

Ex Dividend Date	Dividend Type	Dividend
02-Sep-2024	DIVIDEND	3
07-Sep-2023	DIVIDEND	3
04-Aug-2022	DIVIDEND	3
05-Aug-2021	DIVIDEND	1.5
05-Nov-2020	INTERIM DIVIDEND	1.5

SPLIT / BONUS BY KOPRAN LIMITED

No Split / Bonus details found

Data feed Source : www.accordfintech.com, NSE DATA Feed & BSE Data Feed

Facebook

Twitter

To TOP

Kopran Limited

Kopran Limited share price

CONSOLIDATED QUARTERLY RESULT FOR KOPRAN LIMITED

STANDALONE QUARTERLY RESULT FOR KOPRAN LIMITED

CONSOLIDATED ANNUAL RESULT FOR KOPRAN LIMITED

STANDALONE ANNUAL RESULT FOR KOPRAN LIMITED

CONSOLIDATED PROFIT / LOSS FOR KOPRAN LIMITED

STANDALONE PROFIT / LOSS FOR KOPRAN LIMITED

CONSOLIDATED CASH FLOW FOR KOPRAN LIMITED

STANDALONE CASH FLOW FOR KOPRAN LIMITED

CONSOLIDATED BALANCE SHEET FOR KOPRAN LIMITED

STANDALONE BALANCE SHEET FOR KOPRAN LIMITED

FINANCIAL RATIOS (CONSOLIDATED) FOR KOPRAN LIMITED

FINANCIAL RATIOS (STANDALONE) FOR KOPRAN LIMITED

SHARE HOLDING PATTERN FOR KOPRAN LIMITED

PEER COMPARISON FOR KOPRAN LIMITED

CORPORATE ACTIONS FOR KOPRAN LIMITED

CORPORATE ANNOUNCEMENTS FOR KOPRAN LIMITED

INSIDER TRADING FOR KOPRAN LIMITED

BULK BLOCK DEALS FOR KOPRAN LIMITED

DIVIDEND BY KOPRAN LIMITED

SPLIT / BONUS BY KOPRAN LIMITED